Metabolic bone disease Flashcards
define osteoporosis
syndrome associated with low bone mineral density and microarchitectural deterioration of bone tissue leading to an increased risk of fractures
asymptomatic until fractures occur
risk of fractures rise as bone density falls
basic pathophys of osteoporosis 2
imbalance between bone formation and bone resorption
increased activity of both osteoclasts and osteoblasts leads to bone loss and osteoclast resoprtion takes weeks and osteoblast bone formation takes months
microscopically
-loss of trabecular bone (both mineralised and collagen components)
risk factors for osteoporosis reducing bone density 9
deficiency of oestrogen in females
deficiencey of androgens in males
sharp drop in bone density in early menopause (multifactorial)
endocrine
-DM
-hyperthyroidism
-hyperparathyroidism
GI conditions
-crohns
-UC
-coeliac diseae
-chronic pancreatitis
CKD
Chronic liver disease
COPD
immobility
BMI <18.5
risk factors for osteoprosis independent of bone denisty 7
age-
oral corticosteroids
smoking
alcohol
previous fragility fracture
rheumatolgy conditions: RA, other arthropathies
parental history of hip fracture
risk factors for osteoporosis mechanism unclear 6
SSRIS
PPIs
anticonvulsants- carbamazepine
aromatase inhibor
GnRH antagonists
TZDs
define bone mineral denisty
measure of amount of bone mineralisation
measured with DEXA scan
define DEXA scan
compares observed BMD with that of normal young adult (T-score)
and that of aged-matched controls (Z score)
measured at lumbar spine (L1+4) + Femoral neck
how is osteoporosis defined by DEXA scnan
T score <-2.5
> -1=normal
<-1 but >-2.5 represents osteopaenia
> -2.5 & fracture= osteoporosis
describe common fragility fractures
occurs with low energy mechanisms that would not normally be expected to result in a fracture
most commonly simple fall:
-hip fractures
-vertebral (crush) fractures
-distal radius fractures
-humeral neck fractures
tools to determine fracture risk 3
FRAX
-fracture risk assessment tool
Qfracture
DEXA
who should undergo assessment of fragility fracture risk
all women age 65y and older
men age 75 and older
regardless of clinical risk factors
all women 50-64 and men 50-74 with:
-previous osteoporosis fragility fractures
-use of oral steroids
-Hx of falls
-low BMI
-smoker
-high alcohol intake
people under 50 with:
-current or frequent oral steroid use
-untreated premature menopause
-previous fragility fracture
considerations for treatment of osteoporosis
exclude non-osteoporotic causes for fragility fractures:
-metastatic disease
-Myeloma
-osteomalcia
-Pagets
exclude vit D deficiency and inadequate calcium intake
treatment for osteoporosis 8
excersise- weight bearing activity
reduce fizzy drinks - esp colas
HRT for menopause <40yo
vit D ± calcium (if calcium intake inadequate)
bisphosphonates
raloxifene
calcitonin
denosumab
MOA of bisphosphonates
reduce bone resporption and bone tunrover
*-issues with compliance
MOA of raloxifine
selective oestrogen receptor modulation (SERM)
agonist on bone and cholesterol
antagonist on mammary/uterine tissue